GALLO, Antonio
 Distribuzione geografica
Continente #
EU - Europa 3.428
NA - Nord America 2.638
AS - Asia 616
OC - Oceania 4
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
Totale 6.694
Nazione #
US - Stati Uniti d'America 2.625
IE - Irlanda 1.019
IT - Italia 1.009
GB - Regno Unito 340
UA - Ucraina 275
CN - Cina 238
DE - Germania 231
SG - Singapore 229
SE - Svezia 126
AT - Austria 107
TR - Turchia 101
FR - Francia 84
FI - Finlandia 81
GR - Grecia 70
NL - Olanda 24
BE - Belgio 22
KR - Corea 12
CA - Canada 11
IR - Iran 10
CZ - Repubblica Ceca 7
ES - Italia 6
JP - Giappone 6
RU - Federazione Russa 6
VN - Vietnam 6
CH - Svizzera 5
IN - India 5
AU - Australia 4
HK - Hong Kong 4
EU - Europa 3
EC - Ecuador 2
HR - Croazia 2
IL - Israele 2
MX - Messico 2
PL - Polonia 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
AL - Albania 1
AR - Argentina 1
BG - Bulgaria 1
BR - Brasile 1
BY - Bielorussia 1
CY - Cipro 1
DZ - Algeria 1
MK - Macedonia 1
PK - Pakistan 1
TW - Taiwan 1
Totale 6.694
Città #
Dublin 1.017
Jacksonville 448
Chandler 390
Santa Clara 333
Singapore 170
Princeton 130
Naples 122
Caserta 114
Ann Arbor 113
Roxbury 106
Vienna 106
Medford 94
New York 86
Beijing 65
Bremen 64
Wilmington 60
Woodbridge 56
Boardman 55
Rome 44
Norwalk 42
Nanjing 41
Cambridge 40
San Mateo 40
Milan 33
Napoli 32
Munich 27
Quarto 27
Des Moines 26
Brussels 22
London 21
Aversa 18
Jinan 18
Mountain View 15
Shenyang 15
Ashburn 13
Houston 11
Redwood City 11
Reggio Emilia 11
Seoul 11
Turin 11
Verona 11
Auburn Hills 10
Istanbul 10
Amsterdam 9
Genoa 9
Lappeenranta 9
Düsseldorf 8
Falls Church 8
Cercola 7
Fairfield 7
Florence 7
Kunming 7
Lanzhou 7
Sala Consilina 7
Dong Ket 6
Guangzhou 6
Haikou 6
Helsinki 6
Nanchang 6
Santa Maria Capua Vetere 6
Bologna 5
Brescia 5
Brno 5
Groningen 5
Hebei 5
Padova 5
Pisa 5
Tokyo 5
Buffalo 4
Busto Arsizio 4
Gorgonzola 4
Gunzenhausen 4
Hong Kong 4
Montreal 4
Ningbo 4
Salerno 4
Shanghai 4
Taiyuan 4
Taizhou 4
Tianjin 4
Bacoli 3
Bari 3
Bedford 3
Boydton 3
Buscate 3
Livorno 3
Los Angeles 3
Luzzano 3
Nürnberg 3
Palermo 3
Parabiago 3
Phoenix 3
San Vito di Cadore 3
Siena 3
Tappahannock 3
Toronto 3
Trecase 3
Trentola-Ducenta 3
Treviso 3
Turi 3
Totale 4.358
Nome #
Anxiety in Multiple Sclerosis: Psychometric properties of the State-Trait Anxiety Inventory 498
Computer-aided cognitive rehabilitation improves cognitive performances and induces brain functional connectivity changes in relapsing remitting multiple sclerosis patients: an exploratory study. 106
Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study. 104
Visual resting-state network in relapsing-remitting MS with and without previous optic neuritis 101
Dilated Virchow-Robin spaces and multiple sclerosis: 3 T magnetic resonance study. 99
Distributed changes in default-mode resting-state connectivity in multiple sclerosis 99
Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus. 93
Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume 91
Default mode network changes in multiple sclerosis: A link between depression and cognitive impairment? 90
Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis. 84
Advantages of QBI in TBSS analyses. 83
Fatigue in multiple sclerosis: The contribution of occult white matter damage. 83
Cognitive reserve and neuropsychological performance in multiple sclerosis: A meta-analysis 82
Frontotemporal cortical thinning in amyotrophic lateral sclerosis. 81
Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study. 77
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients. 77
The role of diet in multiple sclerosis: A review 76
INFRATENTORIAL PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN A PATIENT TREATED WITH FLUDARABINE AND RITUXIMAB 71
Quality of life in women with multiple sclerosis and overactive bladder syndrome 70
T(1) cortical hypointensities and their association with cognitive disability in multiple sclerosis 69
BDNF Val66Met polymorphism and brain volumes in multiple sclerosis 69
Dilated perivascular spaces and fatigue: is there a link? Magnetic resonance retrospective 3Tesla study 69
Functional correlates of cognitive dysfunction in multiple sclerosis: A multicenter fMRI Study. 68
A simple measure of cognitive reserve is relevant for cognitive performance in MS patients 68
Brain atrophy and fatigue in relapsing-remitting multiple sclerosis patients: a 3T study 67
Fatigue in multiple sclerosis: The contribution of resting-state functional connectivity reorganization 67
Axonal injury and overall tissue loss are not related in primary progressive multiple sclerosis 64
Assessing response to interferon-β in a multicenter dataset of patients with MS 64
Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience? 64
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study. 63
Proton spectroscopic imaging - Principles and clinical applications in neurology 63
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases. 62
Axonal injury in early multiple sclerosis is irreversible and independent of the short-term disease evolution 62
A brain magnetization transfer MRI study with a clinical follow up of about four years in patients with clinically isolated syndromes suggestive of multiple sclerosis 62
dVRS and Fatigue: is there a link? Magnetic Resonance retrospective 3T study 61
Cognitive performance in multiple sclerosis: the contribution of intellectual enrichment and brain MRI measures 61
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group. 59
Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years 59
NEUROIMAGING NEI DISTURBI DELL’UMORE 59
Regional changes in thalamic shape and volume are related to cognitive performance in multiple sclerosis 57
Malattie del Sistema nervoso Autonomo 56
Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS 56
Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosis. 55
Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study 55
The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS 55
Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype 54
Hirayama disease: three cases assessed by F wave, somatosensory and motor evoked potentials and magnetic resonance imaging not supporting flexion myelopathy. 54
Multiparametric MRI in a patient with adult-onset leukoencephalopathy with vanishing white matter 54
A semiautomatic method for multiple sclerosis lesion segmentation on Dual-Echo MR imaging: Application in a multicenter context 54
Does cognitive reserve play any role in multiple sclerosis? A meta-analytic study 53
Quality and Quantity of Diffuse and Focal White Matter Disease and Cognitive Disability of Patients with Multiple Sclerosis 52
The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence 52
Two-year macular volume assessment in multiple sclerosis patients treated with fingolimod 52
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 51
Extra-motor involvement in ALS patients: a cortical thickeness 3T MRI study 51
Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI 50
The Contribution of Resting State Networks to the Study of Cortical Reorganization in MS. 50
Cognitive impairment and its relation to imaging measures in multiple sclerosis: a study using a computerized battery. 49
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy. 47
Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study. 47
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 47
Morphostructural MRI abnormalities related to neuropsychiatric disorders associated to multiple sclerosis. 46
Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study 46
Validity and reproducibility of the Italian version of the patient determined disease steps scale in people with multiple sclerosis 46
Resting-State Functional Correlates of Social Cognition in Multiple Sclerosis: An Explorative Study 46
Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab 46
A multiparametric brain and cord MR imaging study of a patient with Hirayama disease. 45
An MT MRI study of the cervical cord in clinically isolated syndromes suggestive of MS 44
Functional plasticity of the visual system in multiple sclerosis. 44
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 44
Mean diffusivity and fractional anisotropy histogram analysis of the cervical cord in MS patients 43
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 40
The Relationships Between Cognitive Reserve and Psychological Symptoms: A Cross-Sectional Study in Healthy Individuals 40
Correction to: Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study (Journal of Neurology, (2022), 269, 3, (1610-1617), 10.1007/s00415-021-10737-w) 40
Relationship of Cortical Atrophy to Fatigue in Patients With Multiple Sclerosis 39
NEURORADIOLOGIA E SCLEROSI MULTIPLA 39
Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis 39
The psychological impact of Covid-19 pandemic on people with Multiple Sclerosis: A meta-analysis 39
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration 39
Correlates of executive functions in multiple sclerosis based on structural and functional mr imaging: Insights from a multicenter study 38
Health-Related Coping and Social Interaction in People with Multiple Sclerosis Supported by a Social Network: Pilot Study With a New Methodological Approach 38
Two Unexpected Cases of Rosacea during Fingolimod Therapy 38
Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab 38
Impaired metabolic capacity in the perirhinal and posterior parietal cortex lead to dissociation between attentional, motivational and spatial components of exploration in the Naples High-Excitability rat 37
Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab 37
Pyramidal tract lesions and movement-associated cortical recruitment in patients with MS 36
Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod 36
Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis 36
The effect of IFN-beta on black holes in patients with multiple sclerosis 35
Multiple sclerosis patients and immunomodulation therapies: the potential role of new MRI techniques to assess responders versus non-responders 35
The management of multiple sclerosis by reference centers in south of Italy: a 2011 survey on health demands and needs in Campania region. 35
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 35
Diffusion-tensor magnetic resonance imaging detects normal-appearing white matter damage unrelated to short-term disease activity in patients at the earliest clinical stage of multiple sclerosis 33
Distinctive structural and functional MRI footprint for cognitive dysfunction in pediatric MS? 32
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 32
Coping strategies in relapsing-remitting multiple sclerosis non-depressed patients and their associations with disease activity 31
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study 31
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 30
Longitudinal cortical thinning progression differs across multiple sclerosis phenotypes and is clinically relevant: A multicentre study 30
A real-world study of alemtuzumab in a cohort of Italian patients 30
Totale 5.984
Categoria #
all - tutte 33.094
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.094


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020384 0 0 0 0 79 23 107 12 86 29 23 25
2020/2021830 59 3 76 61 185 16 122 87 17 81 93 30
2021/2022966 53 19 23 37 293 27 25 42 60 66 71 250
2022/20231.799 181 22 34 128 172 133 7 87 950 26 26 33
2023/20241.082 72 37 54 107 263 121 69 29 45 22 109 154
2024/2025756 22 36 43 100 555 0 0 0 0 0 0 0
Totale 7.135